Tips for Celebrating Thanksgiving During the COVID-19 Pandemic
Health care professionals can continue to educate their communities about the importance of correct and consistent mask wearing, frequent handwashing, and social distancing.
Related Articles
RSV Vaccine Could Prevent Increased Risk of Disease Among Individuals Aged 18 to 59
The results displayed well tolerability and safety with Abrysvo, meeting the study’s co-primary endpoint of immunogenicity and primary safety
Middletown Pharmacy and Wellness Staff Care for the Community
Tara Schneider, PharmD, and her husband, Chuck Schneider, MBA, offer expanded clinical services in their Louisville, Kentucky, pharmacy.
Durvalumab With Chemotherapy Shows Long-Term Overall Survival at 3 Years
The results were the longest survival follow-up ever reported for a phase 3 trial for biliary tract cancer.
Climate Change Increases Rate of Infectious Diseases, Expert Says
Speaker Monica Diaz describes the detrimental impact climate change has on the transmission and increases in infectious disease cases.
Identifying and Screening for Hepatic Encephalopathy Risk Factors
Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, delve into the complexities of hepatic encephalopathy, exploring the various risk factors…
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
IMPACT CKD, a modeling analysis created by AstraZeneca, includes data about chronic kidney disease across 8 countries, including the United States.
FDA Approves Ustekinumab Biosimilar to Stelara for Treatment of Plaque Psoriasis
Ustekinumab (Stelara; Janssen Immunology) is a human monoclonal antibody that treats immune-mediated diseases such as psoriasis and psoriatic arthritis.
Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events
Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.
Semaglutide’s New Indication Highlights Growing Role of GLP-1 Receptor Agonists
The latest FDA approval paves the way for expanded use of GLP-1 receptor agonists in patients without diabetes.
Study Details Benefits, Therapeutic Effects of Medical Marijuana on Patients’ Quality of Life
The study is the first of 5 studies co-published by AYR Wellness and LECOM and showcases improvements in physical, social, and mental well-being with minimal…